LIFETECH SCI (01302) · Company profile · Eqvero

LIFETECH SCI

01302HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.37 bn CNY	1.3 bn CNY	1.27 bn CNY	1.1 bn CNY	925.33 m CNY
Cost of revenue	247.57 m CNY	234.27 m CNY	194.38 m CNY	156.28 m CNY	115.75 m CNY
Research and development expense	242.66 m CNY	302.92 m CNY	297.92 m CNY	208.48 m CNY	145.89 m CNY
Selling, general and administrative expense	609.02 m CNY	504.2 m CNY	414.59 m CNY	347.7 m CNY	291.18 m CNY
Operating profit after depreciation	195.41 m CNY	209.71 m CNY	328.5 m CNY	361.57 m CNY	372.48 m CNY
Operating profit before depreciation	298.5 m CNY	297.71 m CNY	405.65 m CNY	428.68 m CNY	434.53 m CNY
EBIT	195.41 m CNY	209.71 m CNY	328.5 m CNY	361.57 m CNY	372.48 m CNY
EBITDA	298.5 m CNY	297.71 m CNY	405.65 m CNY	428.68 m CNY	434.53 m CNY
Interest expense	210 k CNY	1.89 m CNY	722 k CNY	632 k CNY	2.61 m CNY
Profit before tax	191.45 m CNY	199 m CNY	175.58 m CNY	378.05 m CNY	332.93 m CNY
Income tax expense	79.08 m CNY	30.5 m CNY	68.09 m CNY	59.31 m CNY	49.57 m CNY
Income before extraordinary items	147.83 m CNY	222.39 m CNY	263.24 m CNY	325.34 m CNY	292.47 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.